282 results match your criteria: "Department of Clinical Research and Development[Affiliation]"
Intensive Crit Care Nurs
February 2025
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai
Int J Cardiol
November 2024
Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, Gaia, Portugal; Université de Lorraine, INSERM,
Intensive Care Med
November 2024
Department of Clinical Research and Development, LUXMED Group, Postępu 21C, 02-676, Warsaw, Poland.
Resuscitation
October 2024
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai
Indian J Gastroenterol
August 2025
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
Eur J Intern Med
January 2025
Department of Clinical Research and Development, LUXMED Group, Warsaw, , Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, , Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@
Intensive Care Med
November 2024
Department of Clinical Research and Development, LUXMED Group, Postępu 21C, 02-676, Warsaw, Poland.
Cardiol J
August 2024
1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
J Clin Med
August 2024
Department of Clinical Research and Development, Graduate School of Pharmacy, Showa University, Tokyo 157-8577, Japan.
J Clin Med
August 2024
Department of Clinical Research and Development, LUX MED Group, 02-678 Warsaw, Poland.
We investigated the potential diagnostic role of galectin-3 (Gal-3) in patients presenting with suspected acute coronary syndromes (ACS). We searched PubMed Central, Scopus, EMBASE, and the Cochrane Library from inception until 20 June 2024. We measured effect sizes using odds ratios (OR) with 95% CIs for dichotomous data and mean differences (MD) with CIs for continuous data.
View Article and Find Full Text PDFAm J Emerg Med
November 2024
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Department of Public Health, International European University, Kyiv, Ukraine.
Eur J Intern Med
November 2024
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai
Eur J Investig Health Psychol Educ
July 2024
Post-Graduate School of Occupational Medicine, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Am J Emerg Med
November 2024
Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland. Electronic address:
Healthcare (Basel)
June 2024
Department of Reproductive Health, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
Current evidence suggests that airborne pollutants have a detrimental effect on fetal growth through the emergence of small for gestational age (SGA) or term low birth weight (TLBW). The study's objective was to critically evaluate the available literature on the association between environmental pollution and the incidence of SGA or TLBW occurrence. A comprehensive literature search was conducted across Pubmed/MEDLINE, Web of Science, Cochrane Library, EMBASE, and Google Scholar using predefined inclusion and exclusion criteria.
View Article and Find Full Text PDFEur Neuropsychopharmacol
September 2024
Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Exp Hematol Oncol
June 2024
Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy o
Indian J Gastroenterol
April 2025
Colorectal Cancer Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.
World J Clin Oncol
May 2024
Department of Oncology, Botkin Hospital, Moscow 125284, Russia.
Ultrasound-guided fine-needle aspiration is the standard for evaluating thyroid nodules with a high safety profile and a relatively low number of non-diagnostic cytological findings. Nevertheless, this diagnostic method traditionally has its weak points. Several diagnostic categories such as Bethesda I, III and IV are not reliable for thyroid carcinoma risk assessment.
View Article and Find Full Text PDFExpert Opin Investig Drugs
July 2024
Department of Pulmonary and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Objective: SHR-1703 is a novel humanized IgG1 monoclonal antibody with high IL-5 affinity and prolonged half-life, aiming to control eosinophil-related diseases. The study intended to evaluate pharmacokinetics, pharmacodynamics, immunogenicity, safety, and tolerability of SHR-1703 in healthy subjects.
Methods: A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phase I study was conducted.
Biomedicines
April 2024
Orthopedics and Orthopedic Oncology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, 35128 Padova, Italy.
Cancers (Basel)
April 2024
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Cardiovasc Drugs Ther
February 2025
Hanwa Memorial Hospital, 3-5-8 Minamisumiyoshi, Sumiyoshi-Ku, Osaka, 558-0041, Japan.
Background: Recent large clinical trials have revealed that sodium-glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular outcomes not only in patients with heart failure with reduced ejection fraction, but also in patients with heart failure with mildly reduced or preserved ejection fraction (HFpEF). However, the effect of SGLT2 inhibitors on left ventricular (LV) diastolic function is still controversial.
Methods And Results: The TOP-HFPEF trial (Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus) is a multicenter, double-arm, open-label, confirmatory, investigator-initiated clinical study to investigate the effect of SGLT2 inhibitor on LV diastolic function in patients with HFpEF and type 2 diabetes mellitus.
Int J Syst Evol Microbiol
May 2024
Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Am J Emerg Med
June 2024
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA.